Pain Management Devices Market Size, Share, Trends, Growth and Forecast 2032

Pain Management Devices Market Insights

According to a report from Zion Market Research, the global Pain Management Devices Market was valued at USD 2.65 Billion in 2023 and is projected to hit USD 6.18 Billion by 2032, with a compound annual growth rate (CAGR) of 9.84% during the forecast period 2024-2032.

This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Pain Management Devices Market industry over the next decade.

Request Free Sample

Global Pain Management Devices Market Overview     

The pain management devices market was likely to ascertain the very best development within the years to return due to advanced health care facilities and a rise in the percentage of Cancer Pains everywhere in the world. Moreover, the increasing requirement for long-term pain management amongst the elderly population is probably going to spice up the demand for the global pain management devices market. Additionally, to present, the adverse impact of drugs paired with unpalatable taste is believed to be in charge of a serious development within the health care industry, which is predicted to flourish the worldwide pain management devices market. Aside from this, the introduction of various pain management devices will possibly elevate the need for pain management devices, thereby enacting the event of the worldwide pain management devices market.

On the opposite hand, the high price of pain management machines might act as a limitation in the event of a worldwide pain management devices market. Increasing R&D is additionally one of the main factors that act as a catalyst for the event of worldwide pain management devices market. For instance, in April 2018, NeuroMetrix declared outcomes from clinical research of its Quell wearable device. It marketed the device’s capability to treat chronic pain. Outcomes from the study were reported in the Journal of Pain Research.

COVID-19 Impact Analysis  

Besides, the COVID-19 outbreak, there's a drastic rise in the demand for healthcare facilities across the world. The increasing corona cases across the world are forcing governments of developed and emerging countries to extend their patient handling capacities. However, nationwide lockdowns have impacted patients who specifically depend on PT or exercise programs as a pain management regimen. Also, many elective procedures, and in-person patient visits have been canceled or rescheduled, which is anticipated to increase the demand for at-home pain treatment. 

Request Free Sample

Growth Factors

The increasing cases of chronic diseases are one of the key factors expected to contribute to the expansion of the market over the forecast period. The rising prevalence of lifestyle disorders, like obesity and diabetes, has increased the demand for muscle and nerve stimulators, thereby augmenting market growth. The increasing number of cancer cases are expected to further increase product demand over the forecast period. Moreover, the high prevalence of musculoskeletal disorders, like arthritis, orthopedic degenerative disorders, osteoarthritis, and atrophic arthritis, and a resultant rise in cases of chronic pain and inability to hold out routine tasks, will boost product demand.

Pain Management Devices Market: Report Scope

Application Segment Analysis Preview  

Based on application, the global pain management devices market is split into five types like neuropathic pain, cancer pain, musculoskeletal pain, facial & migraine pain, among others. In the application section, neuropathic pain was the dominating section in 2017. This neuropathic pain section was expected to ascertain the very best development within the years to return, majorly due to the high occurrence of diseases resulting in neuropathic pain. Almost over 70% of adults experience back pain, which comes below neuropathic pain. This development of the pain device management market is additionally mainly credited to the increase in the number of Cancer Pains paired with the increment within the number of doctors everywhere on the planet.

Product Segment Analysis Preview  

The neurostimulation segment held the most important revenue share of 57.5% in 2019. the expansion is often attributed to the increased prevalence of neurological disorders. These neurostimulators play an important role in treating chronic pain, Parkinson’s disease, epilepsy, movement disorders, and depression. additionally, certain factors like escalating product demand, the introduction of technologically advanced products, and therefore the growing geriatric population are anticipated to spice up the segment growth.

Request Free Sample

Regional Analysis Preview

Based on geography, North America was the dominant area for the global pain management devices market in 2017 in terms of income. This was owing to the expansion of novel pain management machines within the healthcare market, thereby boosting the worldwide pain management devices market.

The APAC market is estimated to grow at a promising CAGR during the forecast period. Factors like the increasing number of cancer patients, growth within the elderly population, healthcare infrastructure improvements, and therefore the increasing prevalence of chronic diseases are the main factors driving market growth within the Asia Pacific.

Request Free Sample

Key Market Players & Competitive Landscape

The major players that are comprised in Pain Management Devices market are major players such as -

• Boston Scientific Corporation
• Baxter International Inc.
• Kimberly-Clark Corporation
• DJO Global LLC
• Medtronic
• Smiths Medical
• Codman And Shurtleff
• St. Jude Medical
• Hospira Inc.
• Stryker Corporation.

The global  Pain Management Devices Market is segmented as follows:

By Type

• Electrical Stimulators
• TENS
• Analgesic Pumps
• Intrathecal Pumps
• Radiofrequency Ablation Devices
• Neurostimulators
• Spinal Cord Stimulators
• Sacral Nerve Stimulators
• Deep Brain Stimulators 
• Others 

By Application

• Cancer Pain
• Neuropathic Pain
• Facial & Migraine Pain
• Musculoskeletal Pain 
• Others 

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa